These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3491556)

  • 1. Characterization of beta-lactamases in Mycobacterium fortuitum including a role in beta-lactam resistance and evidence of partial inducibility.
    Nash DR; Wallace RJ; Steingrube VA; Udou T; Steele LC; Forrester GD
    Am Rev Respir Dis; 1986 Dec; 134(6):1276-82. PubMed ID: 3491556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoelectric focusing of beta-lactamases in Mycobacterium fortuitum. Association of a single enzyme pattern with cefoxitin resistance.
    Wallace RJ; Nash DR; Udou T; Steingrube VA; Steele LC; Swenson JM; Silcox VA
    Am Rev Respir Dis; 1985 Nov; 132(5):1093-7. PubMed ID: 3877482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-lactamase of Mycobacterium fortuitum: kinetics of production and relationship with resistance to beta-lactam antibiotics.
    Fattorini L; Scardaci G; Jin SH; Amicosante G; Franceschini N; Oratore A; Orefici G
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1760-4. PubMed ID: 1952844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and characterization of beta-lactamases of mycobacteria and related organisms.
    Kwon HH; Tomioka H; Saito H
    Tuber Lung Dis; 1995 Apr; 76(2):141-8. PubMed ID: 7780097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors and inactivators of beta-lactamase from Mycobacterium fortuitum.
    Fattorini L; Amicosante G; Fiorentino D; Franceschini N; Di Marzio L; Oratore A; Orefici G
    J Chemother; 1989 Oct; 1(5):293-7. PubMed ID: 2585031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of beta-lactamase production to the resistance of mycobacteria to beta-lactam antibiotics.
    Quinting B; Reyrat JM; Monnaie D; Amicosante G; Pelicic V; Gicquel B; Frère JM; Galleni M
    FEBS Lett; 1997 Apr; 406(3):275-8. PubMed ID: 9136901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoelectric focusing patterns of beta-lactamases in the rapidly growing mycobacteria.
    Zhang Y; Wallace RJ; Steingrube VA; Brown BA; Nash R; Silcox A; Tsukamura M
    Tuber Lung Dis; 1992 Dec; 73(6):337-44. PubMed ID: 1292713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial characterization of Nocardia farcinica beta-lactamases.
    Steingrube VA; Wallace RJ; Brown BA; Zhang Y; Steele LC; Young G; Nash DR
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1850-5. PubMed ID: 8239595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Lactamase inhibitors and the inducibility of the beta-lactamase of Mycobacterium tuberculosis.
    Zhang Y; Steingrube VA; Wallace RJ
    Am Rev Respir Dis; 1992 Mar; 145(3):657-60. PubMed ID: 1546847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-lactamase production and biological characteristics in nitrosoguanidine induced Mycobacterium fortuitum mutants.
    Fattorini L; Fiorentino D; Amicosante G; Franceschini N; Oratore A; Orefici G
    Acta Leprol; 1989; 7 Suppl 1():44-7. PubMed ID: 2504003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.
    Vanjak D; Muller-Serieys C; Picard B; Bergogne-Berezin E; Lambert-Zechovsky N
    Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):972-8. PubMed ID: 8654448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum.
    Wallace RJ; Brown BA; Silcox VA; Tsukamura M; Nash DR; Steele LC; Steingrube VA; Smith J; Sumter G; Zhang YS
    J Infect Dis; 1991 Mar; 163(3):598-603. PubMed ID: 1995732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalothin in combination with clavulanic acid.
    Cynamon MH; Palmer GS
    Antimicrob Agents Chemother; 1983 Jun; 23(6):935-7. PubMed ID: 6604496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenotypes of beta-lactam resistance in the genus Aeromonas].
    Fosse T; Giraud-Morin C; Madinier I
    Pathol Biol (Paris); 2003 Jul; 51(5):290-6. PubMed ID: 14567197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactam resistance in Nocardia brasiliensis is mediated by beta-lactamase and reversed in the presence of clavulanic acid.
    Wallace RJ; Nash DR; Johnson WK; Steele LC; Steingrube VA
    J Infect Dis; 1987 Dec; 156(6):959-66. PubMed ID: 3500241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of resistance to beta-lactam agents in Pseudomonas aeruginosa with group I beta-lactamases in Spain.
    Colom K; Fdz-Aranguiz A; Suinaga E; Cisterna R
    Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):964-71. PubMed ID: 8654447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-lactamases and beta-lactamase inhibitors.
    Williams JD
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S3-7; discussion S26-7. PubMed ID: 10526867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a beta-lactamase-stable antibiotic.
    Prabhakaran K; Harris EB; Randhawa B; Hastings RC
    Microbios; 1995; 81(328):177-85. PubMed ID: 7752957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal.
    Féria C; Ferreira E; Correia JD; Gonçalves J; Caniça M
    J Antimicrob Chemother; 2002 Jan; 49(1):77-85. PubMed ID: 11751770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of resistance to beta-lactam agents in enterobacteriaceae species with group I beta-lactamases in Spain.
    Colom K; Fernández-Aranguiz A; Alonso R; Suinaga E; Cisterna R
    Microb Drug Resist; 1996; 2(3):353-9. PubMed ID: 9158795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.